First Quadrant’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-5,498
Closed -$255K 714
2019
Q1
$255K Buy
5,498
+1,125
+26% +$57K 0.02% 459
2018
Q4
$215K Sell
4,373
-290,121
-99% -$16.5M 0.02% 523
2018
Q3
$18.3M Hold
294,494
0.41% 87
2018
Q2
$15.9M Buy
+294,494
New +$14.7M 0.3% 115
2015
Q2
Sell
-1,760
Closed -$62K 791
2015
Q1
$62K Sell
1,760
-27,905
-94% -$955K ﹤0.01% 634
2014
Q4
$908K Buy
29,665
+5,405
+22% +$169K 0.02% 365
2014
Q3
$712K Buy
24,260
+22,500
+1,278% +$686K 0.02% 404
2014
Q2
$50K Sell
1,760
-31,173
-95% -$869K ﹤0.01% 698
2014
Q1
$941K Hold
32,933
0.02% 379
2013
Q4
$873K Hold
32,933
0.02% 396
2013
Q3
$903K Hold
32,933
0.02% 382
2013
Q2
$755K Buy
+32,933
New +$744K 0.02% 389

Other funds holding EHC

First Quadrant's EHC Position: Q2 2019 in Review

First Quadrant sold out of Encompass Health (EHC) in Q2 2019, closing a stake of 5,498 shares — an estimated $255K sold.

First Quadrant first reported a position in EHC in Q2 2013 and held it in 12 quarters. The position peaked at $18.3M in Q3 2018. 395 funds tracked by Wall St. Rank hold EHC as of Q2 2019.

  • First Quadrant reported no remaining Encompass Health position as of Q2 2019 after selling out during the quarter.
  • First Quadrant sold 5,498 Encompass Health shares in Q2 2019, an estimated $255K.
  • First Quadrant first reported a position in Encompass Health in Q2 2013 and held it in 12 quarters.
  • First Quadrant's Encompass Health position peaked at $18.3M in Q3 2018.
  • 395 funds tracked by Wall St. Rank held Encompass Health as of Q2 2019.

Based on First Quadrant's 13F filing for Q2 2019, filed 24 Jul 2019.